长春西汀注射液与依达拉奉联合治疗急性脑梗死临床观察

目的：观察长春西汀注射液与依达拉奉联合治疗急性脑梗死的临床疗效。方法：将70例急性脑梗死患者随机分成治疗组和对照组各35例。两组均予常规治疗,应用长春西汀注射液20mg加入250ml生理盐水中静脉滴注,1次/d,治疗组还应用依达拉奉注射液30mg加入250ml生理盐水中静脉滴注,2次/d,14d为1个疗程。采用神经功能缺失评分对两组患者疗效进行评估。结果：治疗组总有效率88.57%,优于对照组62.86%（P〈0.01）,治疗过程中无任何不良反应发生。结论：长春西汀注射液与依达拉奉联合治疗急性脑梗死是安全有效的。

Clinical observation on acute cerebral infarction treated by Vinpocetine injection combined with Edaravone

Objective：To observe the clinical curative effect of acute cerebral infarction treated by Vinpocetine injection combined with Edaravone.Methods：70patients with acute cerebral infarction were randomly divided into treatment group and control group,35 cases in each group.Both groups were carried out the conventional treatment.20 mg Vinpocetine injection was intravenous drip,add250 ml physiological sodium chloride solution 1time/d.in both groups.On this basis,treatment group was given 30 mg Edaravone injection in add in 250 ml of physiological sodium chloride solution,intravenous drip,2times/d,both set to 14 dfor a course of treatment.The lack of nerve function score was used to assess the curative effect.Results：The total effectiveness of treatment group was 88.57%,better than that of the control group 62.86%（P〈0.01）,without any adverse reactions occurred.Conclusion：Vinpocetine injection combined with Edaravone in treatment of acute cerebral infarction is safe and effective.